SCHEMBL5582238

SCHEMBL5582238

COc1c(-c2ccc(C(=O)O)cc2)cc(-c2cccc(Cl)c2)c2cnc(N)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 7/20 0.52
CSNK2A2 P19784 1/20 0.46
CSNK2B P67870 1/20 0.46
CSNK2A1 P68400 1/20 0.46
ADORA1 P30542 4/20 0.44
ADORA2A P29274 3/20 0.44
DHFR P00374 1/20 0.44
PDE4A P27815 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
NEK2 P51955 1/20 0.40
FYN P06241 1/20 0.40
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5581974 0.89 MAP4K4 (0.45) MAP4K4CSNK2A2CSNK2BCSNK2A1ADORA1
SCHEMBL5582212 0.87 CSNK2A1 (0.49) MAP4K4CSNK2A2CSNK2BCSNK2A1ADORA1
SCHEMBL5581752 0.85 PDE4A (0.45) MAP4K4CSNK2A1PDE4APDE4CPDE4D
SCHEMBL5582205 0.84 CSNK2A2 (0.52) MAP4K4CSNK2A2CSNK2BCSNK2A1ADORA1
SCHEMBL5582245 0.84 CSNK2A1 (0.51) MAP4K4CSNK2A2CSNK2BCSNK2A1ADORA1
SCHEMBL5582178 0.83 VNN1 (0.45) MAP4K4CSNK2A2CSNK2BCSNK2A1ADORA1
SCHEMBL5582210 0.83 CSNK2A1 (0.51) MAP4K4CSNK2A2CSNK2BCSNK2A1ADORA1
SCHEMBL5581841 0.82 NPC1 (0.41) MAP4K4PDE4APDE4CPDE4DTUBB4A
SCHEMBL5582252 0.81 VCP (0.44) MAP4K4CSNK2A2CSNK2BCSNK2A1ADORA1
SCHEMBL5581888 0.81 ADORA1 (0.47) ADORA1ADORA2AFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225308-A1 2-Amino Quinazoline Derivative KYOWA HAKKO KOGYO CO.,LTD. (JP) 2007-09-27 US disclosed
EP-1726584-A1 2-AMINOQUINAZOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225308-A1 2-Amino Quinazoline Derivative AGTR2, ABL1, AGTR1 MAP4K4 1461/4885CSNK2A2 467/4885CSNK2B 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.